🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Recruitingn/aAges 18 Years - 110 YearsAllDeutsches Herzzentrum Muenchen
NCT04577248 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age above 18 years and consentable * Mitral Valve Regurgitation, Mitral Valve Stenosis, Tricuspid Valve Regurgitation, Tricuspid Stenosis * Transcatheter mitral or tricuspid valve therapy considered best option by heart-team decision * Written informed consent Exclusion Criteria: * Patient's inability to fully cooperate with the protocol
💊

What it tests

  • edge-to-edge valve repair
📍

Where

1 site
Deutsches Herzzentrum München des Freistaates Bayern, Technische Universität München
Munich, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy